StockClub

SHEZF

SHEZFShenzhen Hepalink Pharmaceutical Group Co., Ltd.$ --
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

SHEZF

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 06/30/2025FY2025 Q2
Revenue
1,423M CNY
YoY -2.8%
Operating Income
305M CNY
YoY -47.9%
Net Income
265M CNY
YoY -47.8%
EPS
0.18CNY
YoY -48.6%

Revenue

CNY2.8B
FY2023 Q3CNY4.1B
CNY4.1B
Q3
FY2023 Q4CNY5.4B
CNY5.4B
Q4
FY2024 Q1CNY1.4B
CNY1.4B
Q1
FY2024 Q2CNY2.8B
CNY2.8B
Q2
FY2024 Q3CNY4.1B
CNY4.1B
Q3
FY2024 Q4CNY5.3B
CNY5.3B
Q4
FY2025 Q1CNY1.4B
CNY1.4B
Q1
FY2025 Q2CNY2.8B
CNY2.8B
Q2
Actual
CNY-15.1M (-0.5%)

Net Income

CNY421.9M
FY2023 Q3CNY143.2M
CNY143.2M
Q3
FY2023 Q4CNY-783.3M
CNY-783.3M
Q4
FY2024 Q1CNY155M
CNY155M
Q1
FY2024 Q2CNY663.7M
CNY663.7M
Q2
FY2024 Q3CNY780.1M
CNY780.1M
Q3
FY2024 Q4CNY646.7M
CNY646.7M
Q4
FY2025 Q1CNY156.6M
CNY156.6M
Q1
FY2025 Q2CNY421.9M
CNY421.9M
Q2
Actual
CNY-241.8M (-36.4%)

Surprise History

Actual RevenueAnalyst Estimate
FY2019MISS
Actual:CNY4.6B
Est:CNY4.7B
FY2019MISS
CNY4.6B
FY2020MISS
Actual:CNY5.3B
Est:CNY5.4B
FY2020MISS
CNY5.3B
FY2021BEAT
Actual:CNY6.4B
Est:CNY6.3B
FY2021BEAT
CNY6.4B
FY2022MISS
Actual:CNY7.2B
Est:CNY7.2B
FY2022MISS
CNY7.2B
FY2023BEAT
Actual:CNY5.4B
Est:CNY5B
FY2023BEAT
CNY5.4B
FY2024BEAT
Actual:CNY5.3B
Est:CNY5.2B
FY2024BEAT
CNY5.3B

Analyst Estimates